Jefferies Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.53M Sell
32,000
-14,091
-31% -$1.36M 0.03% 390
2026
Q2
$3.61M Buy
46,091
+14,091
+44% +$961K 0.02% 484
2026
Q1
$2.07M Buy
32,000
+5,075
+19% +$358K 0.01% 632
2025
Q4
$1.81M Buy
+26,925
New +$1.81M 0.01% 851
2025
Q2
– Sell
-12,263
Closed -$783K – 1527
2025
Q1
$783K Buy
+12,263
New +$712K 0.01% 900
2024
Q1
– Sell
-16,504
Closed -$610K – 1777
2023
Q4
$610K Buy
+16,504
New +$622K ﹤0.01% 1139
2023
Q3
– Sell
-44,250
Closed -$1.81M – 1755
2023
Q2
$1.6M Buy
+44,250
New +$1.51M 0.01% 741

Other funds holding HALO

Jefferies Financial Group's HALO Position: Q3 2026 in Review

Jefferies Financial Group reduced its Halozyme (HALO) stake by 31% in Q3 2026, selling an estimated $1.36M and leaving 32,000 shares worth $3.53M. The position accounts for 0.03% of the portfolio, ranked #390.

Jefferies Financial Group first reported a position in HALO in Q2 2023 and has held it in 7 quarters since. The position peaked at $3.61M in Q2 2026. 773 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Jefferies Financial Group held 32,000 shares of Halozyme worth $3.53M as of Q3 2026.
  • Jefferies Financial Group sold 14,091 Halozyme shares in Q3 2026, an estimated $1.36M.
  • Halozyme made up 0.03% of Jefferies Financial Group's portfolio in Q3 2026, its #390 holding.
  • Jefferies Financial Group first reported a position in Halozyme in Q2 2023 and has held it in 7 quarters since.
  • Jefferies Financial Group's Halozyme position peaked at $3.61M in Q2 2026.
  • 773 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.